Trade DRUG anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Bright Minds Biosciences Inc. (DRUG) is trading at US$72.81, down 2.31% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$759.65M. Over the past 52 weeks, DRUG has traded between US$38.00 and US$123.75. On Syfe you can trade DRUG with $0 commission and add it to your watchlist.
| Previous close | US$74.54 |
|---|---|
| Market cap | US$759.65M |
| 52-week range | US$38.00 – US$123.75 |
| Volume | 107.34K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Bright Minds Biosciences Inc.
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in Chicago, IL.
Year: 2021
Bright Minds Biosciences Inc. (DRUG) stock is trading at US$72.81, -2.31% from the previous close of US$74.54.
The market cap for Bright Minds Biosciences Inc. (DRUG) stock is approximately US$759.65M.
The 52-week high for Bright Minds Biosciences Inc. (DRUG) stock is US$123.75.
The 52-week low for Bright Minds Biosciences Inc. (DRUG) stock is US$38.00.
Bright Minds Biosciences Inc. (DRUG) does not currently pay a dividend.
Stay on top of DRUG
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
